+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell Banking Outsourcing Market by Service Type (Cell Expansion Services, Logistics Services, Quality Control Testing), Cell Type (Mammalian Cells, Microbial Cells, Stem Cells), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011245
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell banking outsourcing is reshaping the operational landscape for biopharmaceutical organizations seeking secure and compliant management of critical cell lines. As the market grows more complex and demands greater efficiency, top industry players and research institutions are increasingly adopting specialized outsourcing to enable streamlined storage, distribution, and quality assurance.

Market Snapshot: Cell Banking Outsourcing Market

The Cell Banking Outsourcing Market grew from USD 14.57 billion in 2024 to USD 16.96 billion in 2025. It is expected to continue growing at a CAGR of 15.68%, reaching USD 34.93 billion by 2030. This rapid expansion is driven by escalating demand for advanced therapies, growing biologics and vaccine pipelines, and stringent regulatory pressures requiring robust third-party quality standards. Increased focus on traceability, operational scalability, and global supply chain security has further positioned cell banking outsourcing as a key function in delivering high-value therapies efficiently.

Scope & Segmentation

This report offers a comprehensive analysis of the cell banking outsourcing market, providing detailed segmentation and coverage across service offerings, technology adoption, application areas, and geographies. Key segmentation highlights include:

  • Service Type: Cell expansion services (custom and standard), logistics services (cold chain, inventory management), quality control testing (genetic characterization, safety, viability), and storage solutions.
  • Cell Type: Mammalian cell lines (CHO, hybridoma, NS0), microbial platforms (E. coli, yeast), and stem cells (hematopoietic, induced pluripotent, mesenchymal).
  • Application: Biopharmaceutical manufacturing, gene therapy (AAV, lentiviral vectors), regenerative medicine (cell therapy, tissue engineering), and vaccine production (recombinant, viral vaccines).
  • End User: Academic institutes, large and small biotechnology companies, contract research organizations (clinical and preclinical), and pharmaceutical companies.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa, and more), Asia-Pacific (China, India, Japan, South Korea, Australia, and others).
  • Companies Covered: Key market players such as Lonza Group AG, Thermo Fisher Scientific Inc., Merck KGaA, Cytiva Uppsala AB, Fujifilm Diosynth Biotechnologies UK Limited, WuXi AppTec Co., Ltd., AGC Biologics Inc., Catalent, Inc., Cobra Biologics Group Limited, and Selexis SA.

Key Takeaways for Senior Decision-Makers

  • Adoption of automation and digitalization in cell processing facilities is significantly enhancing throughput, reducing manual error, and enabling scalable operations.
  • Single-use technologies and modular production suites are providing greater flexibility and minimizing cross-contamination risks, while supporting diverse cell platforms from mammalian to stem cells.
  • Partnerships between biotechnology firms and specialized service providers are increasingly central, as they offer technical expertise, standardized protocols, and high-quality assurance.
  • Regulatory harmonization efforts across major markets are reducing redundant audits, facilitating multi-jurisdictional compliance, and driving competitive differentiation.
  • Environmental sustainability and local sourcing strategies are emerging as important levers in supply chain decisions and operational resilience.
  • Segment-specific growth is mirrored by end-user needs, with divergent requirements shaping service models for academia, large biopharma, and research organizations.

Tariff Impact: Navigating 2025 U.S. Trade Shifts

Imposed U.S. tariffs on specialized cell banking inputs in 2025 have introduced operational cost pressures, prompting organizations to adapt with dual sourcing, stronger supplier qualification, and increased in-house reagent manufacturing. Service providers are expanding domestic logistics infrastructure while collaborating to streamline customs procedures and secure duty relief on critical equipment. These developments emphasize the importance of flexible procurement strategies and risk mitigation.

Methodology & Data Sources

The research is built on both primary and secondary data, including interviews with senior executives from key stakeholder groups. Additional inputs were gathered from scientific literature reviews, industry publications, regulatory documentation, and technology white papers. Rigorous triangulation and analytical frameworks, such as SWOT and PESTEL, underpin the validity of key findings.

Why This Cell Banking Outsourcing Market Report Matters

  • Provides granular insight into emerging industry dynamics, technology integration, and regulatory trends impacting supply chain strategy and compliance.
  • Enables data-driven decision-making for investment and partnership opportunities, supporting more agile and resilient operations in cell therapy development.
  • Guides organizations in identifying tailored market entry or expansion tactics by mapping evolving demands across key regions and segments.

Conclusion

Strategic outsourcing in cell banking is enabling robust, efficient, and compliant biologics and cell therapy pipelines. Senior leaders can leverage insights from this report to fortify operational excellence, drive growth, and respond swiftly to regulatory and market shifts in the cell banking outsourcing ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of single-use bioreactor systems to streamline cell banking workflows and reduce cross-contamination risk
5.2. Integration of advanced digital twin and AI modeling for predictive cell bank performance and process optimization
5.3. Expansion of modular cold chain logistics networks to support global distribution of cryopreserved cell banks
5.4. Implementation of continuous monitoring sensors and IoT platforms for real-time quality control in cell storage facilities
5.5. Emergence of contract development manufacturing organizations offering integrated cell banking and gene editing services
5.6. Regulatory convergence on harmonized global standards driving cell bank characterization and comparability requirements
5.7. Growing demand for customized master cell banks tailored to personalized cell therapy programs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Banking Outsourcing Market, by Service Type
8.1. Introduction
8.2. Cell Expansion Services
8.2.1. Custom Cell Expansion
8.2.2. Standard Cell Expansion
8.3. Logistics Services
8.3.1. Cold Chain Logistics
8.3.2. Inventory Management
8.4. Quality Control Testing
8.4.1. Genetic Characterization
8.4.2. Safety Testing
8.4.3. Viability Testing
8.5. Storage Services
9. Cell Banking Outsourcing Market, by Cell Type
9.1. Introduction
9.2. Mammalian Cells
9.2.1. CHO Cells
9.2.2. Hybridoma Cells
9.2.3. NS0 Cells
9.3. Microbial Cells
9.3.1. E Coli Cells
9.3.2. Yeast Cells
9.4. Stem Cells
9.4.1. Hematopoietic Stem Cells
9.4.2. Induced Pluripotent Stem Cells
9.4.3. Mesenchymal Stem Cells
10. Cell Banking Outsourcing Market, by Application
10.1. Introduction
10.2. Biopharmaceutical Manufacturing
10.2.1. MAb Production
10.2.2. Protein Therapeutics
10.3. Gene Therapy
10.3.1. AAV-Based Therapies
10.3.2. Lentiviral Therapies
10.4. Regenerative Medicine
10.4.1. Cell Therapy
10.4.2. Tissue Engineering
10.5. Vaccine Production
10.5.1. Recombinant Vaccines
10.5.2. Viral Vaccines
11. Cell Banking Outsourcing Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Biotechnology Companies
11.3.1. Large Biotech
11.3.2. Small Biotech
11.4. Contract Research Organizations
11.4.1. Clinical CROs
11.4.2. Preclinical CROs
11.5. Pharmaceutical Companies
12. Americas Cell Banking Outsourcing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cell Banking Outsourcing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cell Banking Outsourcing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lonza Group AG
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Merck KGaA
15.3.4. Cytiva Uppsala AB
15.3.5. Fujifilm Diosynth Biotechnologies UK Limited
15.3.6. WuXi AppTec Co., Ltd.
15.3.7. AGC Biologics Inc.
15.3.8. Catalent, Inc.
15.3.9. Cobra Biologics Group Limited
15.3.10. Selexis SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELL BANKING OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CELL BANKING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CELL BANKING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CELL BANKING OUTSOURCING MARKET: RESEARCHAI
FIGURE 24. CELL BANKING OUTSOURCING MARKET: RESEARCHSTATISTICS
FIGURE 25. CELL BANKING OUTSOURCING MARKET: RESEARCHCONTACTS
FIGURE 26. CELL BANKING OUTSOURCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL BANKING OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 193. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 194. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 195. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 196. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 197. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 198. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 199. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 200. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 201. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 204. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 205. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 206. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 207. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 208. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 209. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 212. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 213. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 214. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 215. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 216. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 217. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 218. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 219. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 222. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 223. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 224. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 232. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 233. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 244. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 245. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 246. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 247. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 250. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 251. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 254. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 255. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell Banking Outsourcing market report include:
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Cytiva Uppsala AB
  • Fujifilm Diosynth Biotechnologies UK Limited
  • WuXi AppTec Co., Ltd.
  • AGC Biologics Inc.
  • Catalent, Inc.
  • Cobra Biologics Group Limited
  • Selexis SA

Table Information